PRDM1 and autoimmune disease: Figure 2 and Figure 3 illustrate the involvement of Blimp-1 in regulating oxidative stress and inflammation across various immune cell types, such as Th17, Tregs, and dendritic cells, highlighting its potential in treating autoimmune diseases like asthma and inflammatory bowel disease by enhancing IL-10 production and antioxidant activity.